Holmium-166 radioembolization
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Holmium-166 radioembolization, covering 2020-06-17 to 2022-11-08. Get the full timeline:
Most recent: Clinical Trial Update: HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients [Phase 2]